Beneficios colaterales en otras infecciones respiratorias durante la lucha contra la COVID-19

Translated title of the contribution: Collateral benefits on other respiratory infections during fighting COVID-19

Khee Siang Chan, Fu Wen Liang, Hung Jen Tang, Han Siong Toh, Wen Liang Yu

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Purpose: Influenza virus infection is associated with a high disease burden. COVID-19 caused by SARS-CoV-2 has become a pandemic outbreak since January 2020. Taiwan has effectively contained COVID-19 community transmission. We aimed to validate whether fighting COVID-19 could help to control other respiratory infections in Taiwan. Method: We collected week-case data of severe influenza, invasive Streptococcus pneumoniae disease and death toll from pneumonia among 25 calendar weeks of the influenza season for four years (2016–2020), which were reported to Taiwan CDC. Trend and slope differences between years were compared. Result: A downturn trend of severe influenza, invasive S. pneumoniae disease and the death toll from pneumonia per week in 2019/2020 season and significant trend difference in comparison to previous seasons were noted, especially after initiation of several disease prevention measures to fight potential COVID-19 outbreak in Taiwan. Conclusions: Fighting COVID-19 achieved collateral benefits on significant reductions of severe influenza burden, invasive S. pneumoniae disease activity, and the death toll from pneumonia reported to CDC in Taiwan.

Translated title of the contributionCollateral benefits on other respiratory infections during fighting COVID-19
Original languageSpanish
Pages (from-to)249-253
Number of pages5
JournalMedicina Clinica
Volume155
Issue number6
DOIs
Publication statusPublished - Sept 25 2020

Keywords

  • COVID-19
  • Influenza
  • Mask
  • SARS-CoV-2
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Collateral benefits on other respiratory infections during fighting COVID-19'. Together they form a unique fingerprint.

Cite this